BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8832149)

  • 1. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome: defining the need for long-term follow-up.
    Small G; Watson AR; Evans JH; Gallagher J
    Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changing clinical course of hemolytic uremic syndrome in children].
    Zurowska A; Gockowska Z; Czarniak P; Marczak E
    Pol Merkur Lekarski; 2000 Apr; 8(46):234-5. PubMed ID: 10897626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome.
    Mehrazma M; Hooman N; Otukesh H
    Iran J Kidney Dis; 2011 Nov; 5(6):380-5. PubMed ID: 22057069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.
    Edefonti A; Bettinelli A; Mondonico P; Claris Appiani A; Picca M; Cossu MM; Tentori F; Giani M; Rossi E
    Clin Nephrol; 1985 Apr; 23(4):207-11. PubMed ID: 4006329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum hemolytic uremic syndrome: a study of three cases with a review of the literature.
    Segonds A; Louradour N; Suc JM; Orfila C
    Clin Nephrol; 1979 Nov; 12(5):229-42. PubMed ID: 389509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults.
    Matsumae T; Takebayashi S; Naito S
    Clin Nephrol; 1996 Mar; 45(3):153-62. PubMed ID: 8706355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
    Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
    Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
    Imoberdorf G; Bianchetti MG; Rossi E; Gugler E; Oetliker OH
    Schweiz Med Wochenschr; 1993 Jul; 123(29):1439-44. PubMed ID: 8367702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.
    Bláhová K; Janda J; Kreisinger J; Matejková E; Sedivá A
    Pediatr Nephrol; 2002 Jun; 17(6):400-3. PubMed ID: 12107802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
    Caletti MG; Gallo G
    Medicina (B Aires); 2005; 65(6):528-32. PubMed ID: 16433483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome in children and arterial hypertension].
    Habib R; Gagnadoux MF; Broyer M
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():37-43. PubMed ID: 6794528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.